14410 studies found for:    ( NOT NOTEXT ) [FIRST-RECEIVED-RESULTS-DATE]
Show Display Options
Rank Status Study
1 Completed
Has Results
Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site
Condition: Neoplasms, Unknown Primary
Interventions: Drug: Etoposide;   Drug: Gemcitabine;   Drug: Irinotecan;   Drug: Paclitaxel;   Drug: Carboplatin
2 Completed
Has Results
Tolerability Comparison of Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin
Condition: Skin Manifestations
Interventions: Drug: adapalene cream 0.1% and adapalene lotion 0.1%;   Drug: adapalene lotion 0.1%
3 Completed
Has Results
Clinical Assessment of Visual Function With the Acrysof ReSTOR Multifocal IOL
Condition: Visual Acuity
Intervention: Device: RESTOR IOL Model SA60D3
4 Completed
Has Results
Efficacy and Safety Study of Fostamatinib Disodium Tablets to Treat T-Cell Lymphoma
Condition: T Cell Lymphoma
Intervention: Drug: Fostamatinib Disodium
5 Completed
Has Results
Preferred Treatment of Type 1.5 Diabetes
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: rosiglitazone;   Drug: glyburide
6 Completed
Has Results
Comparison of Pain of Conventional to Buffered Local Anesthesia During Injection in Pediatric Dental Patients
Condition: Pain
Interventions: Drug: Sodium bicarbonate;   Drug: Lidocaine
7 Completed
Has Results
Safety and Tolerability of Vortioxetine (LuAA21004) - Open Label Extension Study
Condition: Depressive Disorder, Major
Intervention: Drug: Vortioxetine
8 Completed
Has Results
Pilot Study of Preoperative Tarceva (Erlotinib) for Stages I/II Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-small Cell Lung
Intervention: Drug: Tarceva (Erlotinib)
9 Completed
Has Results
Impact of Oral Application of Gastrografin on the Meconium Evacuation in Very Low Birth Weight Infants
Conditions: Meconium Ileus;   Very Low Birth Weight Infant
Interventions: Drug: Gastrografin;   Drug: Sterile water
10 Completed
Has Results
An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease
Condition: Early Stage Parkinson's Disease
Intervention: Drug: Rotigotine
11 Completed
Has Results
Long-term Safety Study of Alogliptin in Participants With Type 2 Diabetes in Japan
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Alogliptin;   Drug: Voglibose
12 Completed
Has Results
Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults
Conditions: HIV;   HIV Infections
Interventions: Drug: Stribild;   Drug: Atripla
13 Completed
Has Results
S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction
Condition: Esophageal Cancer
Interventions: Drug: fluorouracil;   Drug: oxaliplatin;   Procedure: conventional surgery;   Radiation: radiation therapy
14 Completed
Has Results
Efficacy of Combination Therapies for Gonorrhea Treatment
Condition: Gonococcal Infections
Interventions: Drug: Gentamicin;   Drug: Gemifloxacin;   Drug: Azithromycin
15 Completed
Has Results
A 3-arm Multi-center, Randomized Controlled Study Comparing Transforaminal Corticosteroid, Transforaminal Etanercept and Transforaminal Saline for Lumbosacral Radiculopathy
Condition: Lumbosacral Radiculopathy
Interventions: Drug: etanercept;   Drug: methylprednisolone;   Drug: normal saline
16 Completed
Has Results
An Efficacy Study to Compare the Treatment Effects of Rabeprazole and Lansoprazole Depending on the Genotyping of CYP2C19 in Treating Reflux Esophagitis
Condition: Reflux Esophagitis
Interventions: Drug: Rabeprazole;   Drug: Lansoprazole
17 Completed
Has Results
Product Performance of a Toric Contact Lens
Conditions: Myopia;   Astigmatism
Interventions: Device: SofLens DD Toric;   Device: Ciba Vision Focus Dailies Toric Contact Lens
18 Active, not recruiting
Has Results
SPIRIT Small Vessel Registry
Conditions: Coronary Artery Disease;   Atherosclerosis;   Myocardial Ischemia
Intervention: Device: 2.25 mm XIENCE V® Everolimus Eluting Coronary Stent System
19 Completed
Has Results
Campath-1H Plus Rituximab for CD52- and CD20- Positive Refractory or Relapsed Chronic Lymphoid Disorders
Condition: Chronic Lymphocytic Leukemia
Interventions: Drug: Campath-1H;   Drug: Rituximab
20 Completed
Has Results
Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients
Condition: Opiate Addiction
Interventions: Drug: Methadone;   Drug: Buprenorphine/naloxone

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years